Double-blind, placebo-controlled, dose-escalation study to evaluate the pharmacologic effect of CP-690,550 in patients with psoriasis.
Boy MG, Wang C, Wilkinson BE, Chow VF, Clucas AT, Krueger JG, Gaweco AS, Zwillich SH, Changelian PS, Chan G.
J Invest Dermatol. 2009 Sep;129(9):2299-302. Epub 2009 Feb 19. No abstract available. PMID: 19225543 [PubMed - indexed for MEDLINE]Related articles